norfloxacin

Navigate to...

Literature

The publications shown below are associated with this chemical in PharmGKB based on (1) literature annotations, (2) variant annotations, (3) VIP summaries, or (4) pathways.

Filter by PGx Paper Types

Sort by

8 items

Literature

Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype.

Clinical pharmacology and therapeutics. 2023. Gammal Roseann S, Pirmohamed Munir, Somogyi Andrew A, Morris Sarah A, Formea Christine M, Elchynski Amanda L, Oshikoya Kazeem A, McLeod Howard L, Haidar Cyrine E, Whirl-Carrillo Michelle, Klein Teri E, Caudle Kelly E and Relling Mary V.

PGx Paper Type: Implementation

Literature

Human organic cation transporters 1 (SLC22A1), 2 (SLC22A2), and 3 (SLC22A3) as disposition pathways for fluoroquinolone antimicrobials.

Antimicrobial agents and chemotherapy. 2013. Mulgaonkar Aditi, Venitz Jürgen, Gründemann Dirk and Sweet Douglas H.

PGx Paper Type: Drug-Gene Interaction for Pathway

Literature

Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.

Drug safety. 2010. Youngster Ilan, Arcavi Lidia, Schechmaster Renata, Akayzen Yulia, Popliski Hen, Shimonov Janna, Beig Svetlana and Berkovitch Matitiahu.

Literature

Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family.

Xenobiotica; the fate of foreign compounds in biological systems. 2008. Hagenbuch B and Gui C.

Literature

Pharmacokinetics of quinolones: newer aspects.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 1991. Wolfson J S and Hooper D C.

PGx Paper Type: Review, Drug-Gene Interaction for Pathway

Literature

Drugs@FDA: Drug Product norfloxacin (NDA019384)

Literature

Drugs@HCSC: Drug Product Norfloxacin (norfloxacin), AA Pharma Inc.

Literature

Swissmedic label for norfloxacin